Indian kala-azar - Better tools needed for diagnosis and treatment

Journal of Postgraduate Medicine

Volumn 49, Issue 1, 2003, Pages 29-30

  Sundar, S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOGLYCOSIDE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIMONY DERIVATIVE; ATOVAQUONE; FLUCONAZOLE; KETOCONAZOLE; MILTEFOSINE; PENTAMIDINE; SITAMAQUINE;

AMASTIGOTE; ANTIGEN DETECTION; ANTIPROTOZOAL ACTIVITY; ARTICLE; ASPIRATION CYTOLOGY; BONE MARROW BIOPSY; CHILL; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOKALEMIA; IMMUNOFLUORESCENCE TEST; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY DISEASE; LATEX AGGLUTINATION TEST; LEISHMANIA CHAGASI; LEISHMANIASIS; MYOCARDITIS; NEPHROTOXICITY; NONHUMAN; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; RIGOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; VOMITING;

EID: 0038206769     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.931     Document Type: Article

References (14)

1. Sundar S, Rai M. Laboratory Diagnosis of Visceral Leishmaniasis. Clin Diag Lab Immunol 2002;9:951-8.
2. Sundar S, Reed SG, Singh VP, Kumar PCK, Murrary HW. Rapid accurate field diagnosis of visceral leishmaniasis. Lancet 1998;351:563-5.
3. Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB. Use of the recombinant k39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am J Trop Med Hyg 2000;63:153-7.
4. Attar ZJ, Chance ML, el-Safi S, Carney J, Azazy A, EI-Hadi M, et al. Latex agglutination test for detection of urinary antigens in visceral leishmaniasis. Acta Trop 2001;78:11-6.
5. Sundar S. Drug Resistance in Indian visceral leishmaniasis. Trop Med Int Health 2001;6:849-54.
6. Mishra M, Singh MP Choudhury D, Singh VP, Khan AP Amphotericin B for second line treatment of Indian kala-azar (letter). Lancet 1991;37:926.
7. Minutes of the expert group meeting on drug therapy in leishmaniasis held on 29 August 2000. Indian Council of Medical Research, New Delhi.
8. Sundar S, Agrawal NK, Sinha PR, Horwith G, Murray HW. Cure with short-course, low dose amphotericin B lipid complex therapy for Antimony-unresponsive visceral leishmaniasis. Ann Int Med 1997;127:133-7.
9. Sundar S, Jha TK, Thakur CP Mishra M, Singh VR, Buffels R. Low dose liposomal amphotericin B in refractory Indian visceral leishmaniasis-a multicentre study. Am J Trop Med Hyg 2002;66:143-6.
10. Sundar S, Agrawal G, Rai M, Makharia MK, Murray HW. Treatment of Indian visceral leishmaniasis with single or daily infusion of low dose liposomal amphotericin B:randomised trial. BMJ 2001;323:419-22.
11. Jha TK, Olliaro P, Thakur CP, Kanyok TP Singhania BL, Singh IJ, et al. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ 1998;316:1200-5.
12. Sherwood JA, Gachihi GS, Muigai RK, Skillman DR, Mugo M, Rashid JR, et al. Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin Infect Dis 1994;19:1034-9.
13. Sundar S, Rosenkiamer F, Makharia MK, Mandal AK, Voss A, Hilgard P, Murray HW. Trial of miltefosine for visceral leishmaniasis. Lancet 1998;352:1821-4.
14. Sundar S, Jha TK, Thakur CP Engel J, Sindermann H, Fischer C, et al. Oral miltefosine for indian leishmanisis. N Engl J Med 2002;347:1739-46.